Biolife Solutions Inc Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 2.08M2.76M5.66M8.95M6.45M8.23M11.02M19.74M27.37M48.09M119.16M76.24M75.86M82.25M
Cost of Revenue 1.23M1.36M3.37M5.19M2.63M3.45M4.28M6.22M4.70M6.41M14.01M11.67M12.71M9.61M
Gross Profit 0.86M1.40M2.29M3.76M3.81M4.78M6.75M13.53M22.67M41.67M105.15M64.57M63.15M72.64M
Operating items
Amortization - Intangibles 0.22M0.16M1.10M3.03M8.20M4.00M3.52M2.74M
Research & Development 0.32M0.52M0.46M0.49M1.38M2.03M1.19M1.30M3.17M6.72M11.82M8.67M12.07M7.91M
Selling, General & Administrative 1.50M1.83M2.15M2.72M4.87M4.59M4.52M5.95M8.89M15.27M33.67M33.26M43.26M40.54M
Restructuring Costs 0.94M0.67M1.64M0.02M
Other Operating Expenses 0.43M0.27M368.000.84M2.58M3.01M2.09M-3.40M-4.53M1.80M-16.38M40.22M43.96M40.93M
Operating Expenses 2.25M2.61M3.23M4.05M8.83M9.63M7.80M16.08M27.59M54.33M154.32M82.16M99.30M89.38M
Operating Income -1.39M-1.21M-0.94M-0.29M-5.02M-4.85M-1.06M3.66M-0.22M-6.24M-35.16M-5.92M-23.44M-7.13M
EBIT -1.39M-1.21M-0.94M-0.29M-5.02M-4.85M-1.06M3.66M-0.22M-6.24M-35.16M-5.92M-23.44M-7.13M
Non-operating items
Non Operating Investment Income 1.32M0.70M-4.07M
Interest & Investment Income 193.0046.000.28M0.50M0.04M-0.48M-0.28M-1.45M-0.72M
Other Non Operating Income -0.01M0.29M0.66M1.30M0.50M
Non Operating Income -0.59M-0.75M-0.72M-0.80M0.02M-3.19M-1.46M-28.67M-2.98M4.96M6.13M1.07M4.97M-4.30M
Net income details
EBT -1.98M-1.88M-1.68M-1.03M-5.02M-4.95M-2.52M-25.00M-3.20M-1.28M-29.03M-4.85M-18.47M-11.43M
Tax Provisions -1.54M-3.26M-20.12M-5.24M-0.02M-0.04M
Profit After Tax -1.98M-1.96M-1.66M-1.08M-5.00M-8.04M-2.52M-25.00M-1.66M1.98M-8.91M-139.81M-68.00M-20.18M
Equity Income -1.00M-0.67M-0.74M
Income from Non-Controlling Interests -0.78M-1.17M
Income from Continuing Operations -1.98M-1.88M-1.68M-1.03M-5.02M-4.95M-2.52M-25.00M-1.66M1.98M-8.91M0.39M-18.45M-11.39M
Consolidated Net Income -1.98M-1.88M-1.68M-1.03M-5.02M-4.95M-2.52M-25.00M-1.66M1.98M-8.91M-140.19M-49.55M-8.80M
Income towards Parent Company -1.98M-1.88M-1.68M-1.03M-5.02M-4.95M-2.52M-25.00M-1.66M1.98M-8.91M-140.19M-49.55M-8.80M
Preferred Dividend Payments 0.21M0.34M
Net Income towards Common Stockholders -1.98M-1.88M-1.68M-1.03M-5.02M-6.88M-2.73M-25.34M-1.66M1.98M-8.91M-139.81M-66.43M-8.80M
Additional items
EPS (Basic) -0.03-0.03-0.33-0.22-0.35-0.54-0.21-1.56-0.090.07-0.23-3.29-1.55-0.44
EPS (Weighted Average and Diluted) -0.03-0.02-0.210.14-0.09-0.06-0.23-3.25-1.55-0.44
Shares Outstanding (Weighted Average) 4.98M4.98M4.98M5.03M12.24M12.88M13.63M18.50M20.45M32.74M41.65M42.77M44.03M46.39M
Shares Outstanding (Diluted Average) 69.68M69.68M38.50M43.07M43.72M46.07M
EBITDA -1.39M-1.21M-0.94M-0.29M-5.02M-4.85M-1.06M3.66M-0.22M-6.24M-35.16M-5.92M-23.44M-7.13M
Interest Expenses 0.59M0.67M0.73M0.74M0.10M0.19M0.01M0.01M
Tax Rate 48.19%69.31%0.13%0.33%